CEO, Markel Insurance · MARKEL GROUP INC. · Common Stock
Open-market sale
$155K reported value · 4.1% of prior position
Disclosed 0 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Costanzo Brian J.Chief Financial Officer | Other acquisition or disposition | J | $3,000 2 sh | Oct 16, 2026 traded Sep 30, 2026 | |
| 23 | April McClain DelaneyDDependent child | Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 | |
| 16 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Aug 3, 2026 traded Jul 29, 2026 | |
| 16 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Aug 3, 2026 traded Jul 28, 2026 | |
| 16 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Aug 3, 2026 traded Jul 27, 2026 | |
| 27 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Aug 3, 2026 traded Jul 24, 2026 | |
| 20 | Thomas H. Kean, Jr.RSelf | Partial sale | SELL | $1,001 – $15K | Jul 15, 2026 traded Jun 2, 2026 | |
| 16 | Thomas H. Kean, Jr.RSelf | Partial sale | SELL | $1,001 – $15K | Jul 15, 2026 traded Jun 29, 2026 | |
| 24 | April McClain DelaneyDDependent child | Purchase | BUY | $1,001 – $15K | Jun 5, 2026 traded May 1, 2026 | |
| 24 | April McClain DelaneyDDependent child | Purchase | BUY | $1,001 – $15K | May 6, 2026 traded Apr 30, 2026 | |
| 22 | Crowley Andrew G.EVP & Pres., Markel Ventures | Other acquisition or disposition | J | $15K 9 sh | Apr 15, 2026 traded Mar 31, 2026 | |
| 22 | Costanzo Brian J.Chief Financial Officer | Other acquisition or disposition | J | $3,000 2 sh | Apr 15, 2026 traded Mar 31, 2026 | |
| 17 | Wilson SimonEVP and CEO, Markel Insurance | Grant or award | A | — 868 sh | Feb 26, 2026 traded Feb 24, 2026 | |
| 20 | Wilson SimonEVP and CEO, Markel Insurance | Open-market sale | SELL | $208K 100 sh | Feb 26, 2026 traded Feb 26, 2026 | |
| 17 | Grandis Meade P.CAO and Controller | Grant or award | A | — 70 sh | Feb 26, 2026 traded Feb 24, 2026 | |
| 24 | Thomas H. Kean, Jr.RSelf | Partial sale | SELL | $15K – $50K | Feb 19, 2026 traded Jan 23, 2026 | |
| 8 | Wilson SimonCEO, Markel Insurance | Tax withholding | F | $98K 47 sh | Feb 19, 2026 traded Feb 17, 2026 | |
| 12 | Wilson SimonCEO, Markel Insurance | Tax withholding | F | $194K 94 sh | Dec 3, 2025 traded Dec 2, 2025 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $155,471
Wilson Simon filed this Form 4 reporting a open-market sale of MKL on Nov 25, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.